Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 53 % of short-term debt in 2024; threshold 65 %.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2024
AVISTER-MEDICAL from Verviers, company number BE0669862895, closed financial year 2024 with a result of € -99,722 after tax. For that financial year AVISTER-MEDICAL recorded a gross margin of € 28,326 and equity of € 58,820. Compared with financial year 2023, the result moved from € -58,657 to € -99,722. The company made a loss. The buffer shrank hard: equity is 69 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 3, 2025.
€ 58,820
▼ 69% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -99,722
▼ 70 % more loss than in 2023
Profit after tax over the fiscal year.
€ 56
▼ 92% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -296,530.
People and assets in 2024
€ 49,159
▼ 26% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 93,780
▲ 42% vs 2023
€ 30,286 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 118,228
▲ 4% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 16,745
▼ 38% vs 2023
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 28,477 | € 114,405 | € 28,326 | ▼ 75% |
| Profit after taxes | € -84,515 | € -58,657 | € -99,722 | ▼ € 41,065 |
| Equity | € 298,540 | € 189,157 | € 58,820 | ▼ 69% |
| Total debts | € 354,211 | € 334,454 | € 331,726 | ▼ 1% |
| Cash | € 22,338 | € 674 | € 56 | ▼ 92% |
| Retained profit | € -138,151 | € -196,808 | € -296,530 | ▼ € 99,722 |
| Bank debt | € 50,685 | € 65,877 | € 93,780 | ▲ 42% |
| Balance sheet total | € 652,751 | € 523,611 | € 390,546 | ▼ 25% |
By gross margin, AVISTER-MEDICAL ranks 12th of 14 companies with main activity “Detailhandel in farmaceutische producten” in Verviers that publish figures (fiscal year 2024).
Key figures of AVISTER-MEDICAL, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 January 2026.
Ask about AVISTER-MEDICAL the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to AVISTER-MEDICAL?
What happened at AVISTER-MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
AVISTER-MEDICAL is active according to the CBE. Legal situation: Opening faillissement.
- NOSHAQ PARTNERS stepped down as director. NBB
- CLERM SRL stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 99,722. Source: NBB ↗
- NOSHAQ PARTNERS became a director. NBB
- CLERM SRL became a director. NBB
- Marwan ABBOUD stepped down as director. NBB
- Capital increase published in the Gazette. Source: Staatsblad ↗
- Marwan ABBOUD became a director. NBB
In short
From € 84,515 loss in 2022 to € 99,722 loss in 2024.
Paid € 523 in corporate taxes since 2022.
Management
The stake of NOSHAQ EUROPE 3 comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
AVISTER-MEDICALThe shares are held by NOSHAQ EUROPE 3 (42.8%).
Directors
According to the 2024 annual accounts
Director · represented by Laurence Rosa
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +168 more
since 2024 · until 2030
Managing director · represented by Dauvister MARC
since 2024 · until 2030
since 2019 · until 2024
Shareholders
42.8%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue des Déportés 7 box A
4800 Verviers
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Verviers
Same main activity (Detailhandel in farmaceutische producten), 16 active companies in Verviers, largest first.
€ 411,085 gross margin · 2025
€ 370,741 gross margin · 2025
€ 302,084 gross margin · 2025
€ 228,344 gross margin · 2025
€ 226,172 gross margin · 2025
€ 180,198 gross margin · 2025
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
OVH, FR
Domain
Domain
avister-medical.com
Registered
2016-12-11
Registrar
EuroDNS S.A.
Expires
2026-12-11
Website info
Features
Security
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- Marc DAUVISTER(associé) 46.8%
- Société Anonyme NOSHAQ EUROPE 3(nieuwe associé) 42.8%
- Marwan ABBOUD(nieuwe associé) 4.3%
Incorporation
Source: Deed ↗- Marc Daniel Michel DAUVISTER(oprichter) 100%
Details
- Company number
- 0669.862.895
- VAT number
- BE 0669.862.895
- Registered office
- Rue des Déportés 7 bus A, 4800 Verviers
- Names & denominations
- AVISTER-MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 23 January 2017
- Peppol
- Not registered
- Contact
- avister-medical.com
- Activities · NACE
Detailhandel in farmaceutische producten
Overige niet-gespecialiseerde detailhandel
Overige detailhandel in nieuwe artikelen neg
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Detailhandel via postorderbedrijven of via internet